EXHIBIT 16.1 August 17, 2005 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 RE: NOVELOS THERAPEUTICS, INC. Ladies and Gentlemen: We have read the statements made by Novelos Therapeutics, Inc. in Item 4.01(a) of the accompanying Form 8-K, which is being filed with the Securities and Exchange Commission. We agree with the statements contained therein concerning our firm. Very truly yours, /s/ De Joya & Company - ------------------------------ De Joya & Company Henderson, Nevada
Cellectar Biosciences (CLRB) 8-KChanges in Registrant.s Certifying Accountant
Filed: 17 Aug 05, 12:00am